Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
143
-
Total 13F shares, excl. options
-
38,829,903
-
Shares change
-
+3,818,095
-
Total reported value, excl. options
-
$719,936,195
-
Value change
-
+$114,245,771
-
Put/Call ratio
-
279%
-
Number of buys
-
90
-
Number of sells
-
-58
-
Price
-
$18.54
Significant Holders of INTERCEPT PHARMACEUTICALS IN - COM (ICPT) as of Q3 2023
196 filings reported holding ICPT - INTERCEPT PHARMACEUTICALS IN - COM as of Q3 2023.
INTERCEPT PHARMACEUTICALS IN - COM (ICPT) has 143 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38,829,903 shares
.
Largest 10 shareholders include BlackRock Inc. (4,212,820 shares), STATE STREET CORP (3,197,810 shares), UBS Group AG (2,999,188 shares), Magnetar Financial LLC (2,407,209 shares), ALPINE ASSOCIATES MANAGEMENT INC. (2,203,295 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2,077,893 shares), VANGUARD GROUP INC (2,071,232 shares), Jefferies Financial Group Inc. (2,000,000 shares), ALLIANCEBERNSTEIN L.P. (1,542,896 shares), and Pictet Asset Management Holding SA (1,205,093 shares).
This table shows the top 143 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.